More than two-thirds of people with clinically stable myasthenia gravis (MG) have problems with disturbed sleep, with resulting negative effects on their quality of life, a survey study of hundreds of MG patients in China has found. Further, those with sleep problems were significantly more likely to have obstructive…
News
Researchers in the U.K. have identified a distinct immune profile in adults with myasthenia gravis (MG) whose disease does not respond to standard therapies. “Understanding these immune differences brings us closer to predicting how patients will respond to therapy and to developing more targeted, personalised treatment approaches,” Madhvi Menon,…
Less than half of Americans newly diagnosed with myasthenia gravis (MG) are receiving the recommended blood tests to confirm their condition, even though these results are vital for choosing the appropriate treatment. According to new research using real-world U.S. insurance data, many patients are starting MG-specific therapies, including…
Aiming to address a persistent gap in myasthenia gravis (MG) research, Vitaccess is teaming up with the Myasthenia Gravis Foundation of America (MGFA) to expand real-world data collection in MG. As part of the new exclusive agreement, MGFA will become the official collaborator for the Vitaccess Real MG…
Uplizna (inebilizumab), Amgen’s infusion therapy for adults with generalized myasthenia gravis (gMG) who are positive for antibodies targeting acetylcholine receptor (AChR) or muscle-specific kinase (MuSK), is now approved for use in the European Union. The decision by the European Commission — which applies to all EU member states…
Standard treatments helped many people with myasthenia gravis (MG) who lack the most common disease-causing antibodies, according to a new review study. The findings shed new light on how so-called double-seronegative MG (dSNMG) compares with more common forms of the disease and highlight the need for careful monitoring,…
Tofacitinib, an approved medication for some types of inflammatory arthritis and inflammatory bowel disease, improves muscle strength, daily functioning, and quality of life in people with hard-to-treat myasthenia gravis (MG), according to a small pilot clinical trial. Slightly more than half of the participants experienced few or no symptoms…
A new digital platform — MyaLink — enables doctors to monitor the physical and mental health of people with myasthenia gravis (MG) in real time and communicate directly with patients through the app, a study shows. Data collected by MyaLink on MG patients’ symptoms, disease activity, daily functioning, and…
Robotic thymectomy — a surgical removal of the thymus gland using robotic systems — is an effective and safe treatment for people with late-onset myasthenia gravis (MG), including those who develop the rare neuromuscular disease after the age of 65, according to a two-decade-long study in China. Rates…
A single course of six once-weekly infusions of Descartes-08, an investigational CAR T-cell therapy, was well tolerated and resulted in sustained clinically meaningful responses in people with generalized myasthenia gravis (gMG). That’s according to final data from the Phase 2b MG-001 clinical trial (NCT04146051), which also showed…
Recent Posts
- Problems with disturbed sleep affect 2 in 3 people with stable MG: Study
- Distinct immune profile found in treatment-resistant myasthenia gravis
- Loving someone with MG: What partners wish they knew sooner
- In public, my twin brother outsmarts MG with cold air and thick skin
- One troubling aspect of chronic illness is when I find myself losing empathy